Skip to main content
Log in

Effects of Cisapride on Oesophageal Transit of Solids in Patients with Progressive Systemic Sclerosis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In most patients with progressive systemic sclerosis (PSS) the oesophagus is affected. Reflux symptoms are most frequent, whilst dysphagia also occurs. Cisapride, a prokinetic agent, may enhance motility along the gastrointestinal tract. The effects of cisapride on oesophageal transit were evaluated in 12 PSS patient using a solid-phase radionuclide oesophageal transit study. Each PSS patient was given cisapride 10 mg or placebo orally three times a day in a random, double-blind, crossover fashion. The results show that cisapride does not seem to have any impact on oesophageal transit in patients with PSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 1 August 2000 / Accepted: 6 August 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SJ., Lan, JL., Lan, JL. et al. Effects of Cisapride on Oesophageal Transit of Solids in Patients with Progressive Systemic Sclerosis. Clin Rheumatol 21, 43–45 (2002). https://doi.org/10.1007/s100670200010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670200010

Navigation